Successful FDA Audit

Complex peptide no challenge for CPR scientists

With the in-life component of a clinical trial completed, a large multinational pharmaceutical company approached CPR to help develop a peptide assay to complete the bioanalysis to report data before an FDA deadline closed.

< Back to news listings

Join us on